Shionogi Pharma Competitors and Similar CompaniesClear all

Shionogi Pharma's competitors and similar companies include Akums Drugs and Pharmaceuticals, Hypera Pharma, Octapharma and Patheon.

	Shionogi Pharma Shionogi Pharma (シオノギファーマ株式会社) is a company that is active in the pharmaceutical manufacturing and sales industry.	Akums Drugs and Pharmaceuticals Akums Drugs and Pharmaceuticals is a contract development and manufacturing organization (CDMO).	Hypera Pharma Hypera Pharma is a pharmaceutical company that provides medicines and food supplements.	Octapharma Octapharma is one of the largest human protein manufacturers, developing and producing human proteins from human plasma and human cell lines.	Patheon Patheon is a company that provides commercial manufacturing and pharmaceutical development services.
Founding Date	Founding Date 2018	Founding Date 2004	Founding Date 2001	Founding Date 1983	Founding Date 2014
Type	Type Subsidiary	Type Private	Type Public	Type Private	Type Subsidiary
Tags	Tags Manufacturing & Industrial drug development pharma	Tags Healthcare drug development pharma	Tags Manufacturing & Industrial drug development pharma	Tags Manufacturing & Industrial drug development pharma	Tags Manufacturing & Industrial drug development pharma
Locations	Locations Osaka, JP HQ	Locations Delhi, IN HQ Delhi, IN	Locations São Paulo, BR HQ	Locations Lachen, CH HQ Pyrmont, AU Wien, AT Baku, AZ Minsk, BY Anderlecht, BE see more	Locations Mississauga, CA HQ
Employees	Employees 1,460	Employees 4,4829% increase	Employees 10,481	Employees 12,000	Employees 6,500
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) R$7.7b (FY, 2025)	Revenue (est.) €2.5b (FY, 2021)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods R$2.8b (FY, 2025)	Cost of goods €1.7b (FY, 2021)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit R$4.9b (FY, 2025)	Gross profit €808.2m (FY, 2021)	Gross profit N/A
Net income	Net income N/A	Net income N/A	Net income R$1.2b (FY, 2025)	Net income €438.3m (FY, 2021)	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 70m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 150m